Articles

• Mutations in FUS cause FALS and SALS in French and French Canadian populations

  V. V. Belzil, P. N. Valdmanis, P. A. Dion, H. Daoud, E. Kabashi, A. Noreau, J. Gauthier, P. Hince, A. Desjarlais, J. -P. Bouchard, L. Lacomblez, F. Salachas, P. -F. Pradat, W. Camu, V. Meininger, N. Dupré, G. A. Rouleau

  • Abstract
  • Full Text
  • Full Text (PDF)
• Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort

  N. Ticozzi, V. Silani, A. L. LeClerc, P. Keagle, C. Gellera, A. Ratti, F. Taroni, T. J. Kwiatkowski, D. M. McKenna-Yasek, P. C. Sapp, R. H. Brown, J. E. Landers

  • Abstract
  • Full Text
  • Full Text (PDF)
• Follow-up of [¹¹C]PIB uptake and brain volume in patients with Alzheimer disease and controls

  N. M. Scheinin, S. Aalto, J. Koikkalainen, J. Lötjönen, M. Karrasch, N. Kemppainen, M. Viitanen, K. Någren, S. Helin, M. Scheinin, J. O. Rinne

  • Abstract
  • Full Text
  • Full Text (PDF)
• Relationships between biomarkers in aging and dementia

  W. J. Jagust, S. M. Landau, L. M. Shaw, J. Q. Trojanowski, R. A. Koeppe, E. M. Reiman, N. L. Foster, R. C. Petersen, M. W. Weiner, J. C. Price, C. A. Mathis

  • Abstract
  • Full Text
  • Full Text (PDF)
• Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

  F. M. Iwamoto, L. E. Abrey, K. Beal, P. H. Gutin, M. K. Rosenblum, V. E. Reuter, L. M. DeAngelis, A. B. Lassman

  • Abstract
  • Full Text
  • Full Text (PDF)
• Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma

  Kurt A. Jaeckle, Karla Ballman, Alfred Furth, Jan C. Buckner

  • Abstract
  • Full Text
  • Full Text (PDF)
• Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures

  H. Kurahashi, J. -w. Wang, A. Ishii, T. Kojima, S. Wakai, T. Kizawa, Y. Fujimoto, K. Kikkawa, K. Yoshimura, T. Inoue, S. Yasumoto, A. Ogawa, S. Kaneko, S. Hirose

  • Abstract
  • Full Text
  • Full Text (PDF)